Filing Details

Accession Number:
0001140361-18-030008
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-06-26 20:23:49
Reporting Period:
2018-06-22
Accepted Time:
2018-06-26 20:23:49
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1274826 Robert Baffi C/O Biomarin Pharmaceutical Inc.
770 Lindaro St.
San Rafael CA 94901
Evp, Technical Operations No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-06-22 6,949 $14.39 90,225 No 4 M Direct
Common Stock Disposition 2018-06-22 6,621 $99.00 83,604 No 4 S Direct
Common Stock Disposition 2018-06-22 328 $99.01 83,276 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to buy Common Stock) Disposition 2018-06-22 6,949 $0.00 6,949 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2009-11-12 2019-05-11 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 77,055 Indirect Shares held by Baffi Family Trust
Footnotes
  1. Trade made pursuant to a 10b5-1 plan executed on March 6, 2018.
  2. Reflects the number of options outstanding after the transactions from this specific stock option grant.